Streptomycin Export Market Intelligence: India's 57 Suppliers Shipping to 36 Countries — TransData Nexus 2026

Q: Who are the top streptomycin exporters from India?

The top streptomycin exporters from India are: 1. LABORATE PHARMACEUTICALS INDIA LTD — $127.3K (22.2% market share); 2. ASHISH LIFE SCIENCE PRIVATE LIMITED — $92.5K (16.1% market share); 3. MACLEODS PHARMACEUTICALS LTD — $59.0K (10.3% market share); 4. SWISS PARENTERALS LIMITED — $46.8K (8.2% market share); 5. EVOLET HEALTHCARE PRIVATE LIMITED — $34.6K (6.0% market share). Together they account for 62.8% of India's total streptomycin export value.

Q: What is the total export value of streptomycin from India?

The total export value of streptomycin from India is $573.8K USD, recorded across 150 shipment transactions from 57 active exporters to 36 destination countries. The average shipment value is $3.8K.

Q: Which countries import streptomycin from India?

India exports streptomycin to 36 countries worldwide. The top importing countries are: SAUDI ARABIA (28.9% share, $165.7K), NIGERIA (22.2% share, $127.3K), UNITED ARAB EMIRATES (17.1% share, $98.1K), TAJIKISTAN (11.8% share, $67.9K), ALGERIA (8.2% share, $46.8K). These five markets account for 88.2% of total export value.

Q: What is the HS code for streptomycin exports from India?

The primary HS code for streptomycin exports from India is 30041070. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of streptomycin exports from India?

The average unit price for streptomycin exports from India is $6.24 USD per unit, with prices ranging from $0.01 to $259.34 depending on formulation, packaging, and order volume. The total market is valued at $573.8K across 150 shipments.

Q: Which ports handle streptomycin exports from India?

The primary ports for streptomycin exports from India are SAHAR AIR (22.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.7% of shipments), NHAVA SHEVA SEA (INNSA1) (13.3% of shipments), JNPT/ NHAVA SHEVA SEA (4.7% of shipments), JNPT (4.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of streptomycin?

India is one of the world's leading exporters of streptomycin due to its large base of 57 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports streptomycin to 36 countries, demonstrating 18% global market coverage.

Q: What certifications do Indian streptomycin exporters need?

Indian streptomycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import streptomycin from India?

There are 65 registered buyers importing streptomycin from India, spread across 36 countries. The repeat buyer rate is 38.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top streptomycin supplier from India?

LABORATE PHARMACEUTICALS INDIA LTD is the leading streptomycin exporter from India with a market share of 22.2% and total export value of $127.3K across 4 shipments. The top 5 suppliers together control 62.8% of total export value.

Suresh Sormare

Streptomycin

India Pharmaceutical Trade Intelligence

$573.8K57 Suppliers36 CountriesHS 30041070

ExportsIndia → SAUDI ARABIA28.9%India → NIGERIA22.2%

ImportsUNITED ARAB → India$7.6K UNITED STATES → India$25

Streptomycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Streptomycin to the World

Between 2022 and 2026, India exported $573.8K worth of streptomycin across 150 verified shipments to 36 countries — covering 18% of world markets in the Tuberculosis Medications segment. The largest destination is SAUDI ARABIA (28.9%). LABORATE PHARMACEUTICALS INDIA LTD leads with a 22.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Streptomycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Streptomycin export data snapshot — $573.8K · 57 exporters · 36 countriesTransData Nexus · Indian Customs Data

Top Streptomycin Exporters from India

57 active exporters · Ranked by export value

View all 57 →

Top Streptomycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LABORATE PHARMACEUTICALS INDIA LTD	$127.3K	4	1	22.2%
2	ASHISH LIFE SCIENCE PRIVATE LIMITED

Top Countries Importing Streptomycin from India

36 destination markets · Ranked by import value

All 36 countries →

Top Countries Importing Streptomycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SAUDI ARABIA	$165.7K	28.9%
2	NIGERIA	$127.3K	22.2%
3	UNITED ARAB EMIRATES	$98.1K	17.1%
4	TAJIKISTAN	$67.9K	11.8%
5	ALGERIA	$46.8K	8.2%
6	MOZAMBIQUE	$24.1K	4.2%
7	ZIMBABWE	$10.0K	1.7%
8	TURKEY	$9.8K	1.7%
9	SUDAN	$7.2K	1.3%
10	UGANDA	$5.6K	1.0%

SAUDI ARABIA is India's largest streptomycin export destination, absorbing 28.9% of total exports worth $165.7K. The top 5 importing countries — SAUDI ARABIA, NIGERIA, UNITED ARAB EMIRATES, TAJIKISTAN, ALGERIA — together account for 88.2% of India's total streptomycin export value. The remaining 31 destination countries collectively receive the other 11.8%, indicating a focused distribution strategy targeting key markets.

Who Supplies Streptomycin to India?

2 origin countries · Total import value: $7.6K

India imports streptomycin from 2 countries with a combined import value of $7.6K. The largest supplier is UNITED ARAB EMIRATES ($7.6K, 1 shipments), followed by UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Streptomycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED ARAB EMIRATES	$7.6K	1	99.7%
2	UNITED STATES	$25	1	0.3%

UNITED ARAB EMIRATES is the largest supplier of streptomycin to India, accounting for 99.7% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Streptomycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Streptomycin is approved for use in treating tuberculosis and other bacterial infections. The FDA's Orange Book lists several approved Abbreviated New Drug Applications (ANDAs) for Streptomycin, indicating the presence of multiple generic versions in the market. As of March 2026, there are no active import alerts related to Streptomycin, suggesting compliance with FDA standards by current exporters. The regulatory pathway for Streptomycin involves submission of an ANDA, demonstrating bioequivalence to the reference listed drug, and adherence to Current Good Manufacturing Practices (cGMP). Given the 57 active Indian exporters, it is imperative for each to ensure compliance with FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, Streptomycin requires a marketing authorization granted by the European Medicines Agency (EMA) or national competent authorities. The EMA's centralized procedure is applicable for certain medicines, while others may follow decentralized or mutual recognition procedures. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturing sites. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and regulation of medicines, including Streptomycin. Post-Brexit, the UK has established its own regulatory framework, necessitating separate applications for marketing authorization.

3WHO Essential Medicines & Global Standards

Streptomycin is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its importance in treating priority health conditions. The WHO Model List serves as a guide for countries to develop their own national essential medicines lists. Streptomycin is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, Streptomycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medicine. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, Streptomycin is not listed under the Drugs (Prices Control) Order (DPCO), implying no ceiling price is currently imposed. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceuticals, ensuring compliance with export regulations.

5Patent & Exclusivity Status

Streptomycin, discovered in the 1940s, is no longer under patent protection, allowing for generic manufacturing and export without infringement concerns. The absence of patent restrictions has led to a competitive market with multiple manufacturers producing Streptomycin, contributing to its widespread availability and affordability.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List, reaffirming Streptomycin's inclusion due to its critical role in treating tuberculosis and other bacterial infections. This underscores the global recognition of Streptomycin's importance in public health.

In January 2026, the WHO published a fact sheet emphasizing the significance of essential medicines, including Streptomycin, in addressing priority health-care needs. The document highlights the necessity for these medicines to be available, affordable, and of assured quality at all times, aligning with the principles of universal health coverage. (who.int)

These developments reflect the ongoing global commitment to ensuring access to essential medicines like Streptomycin, reinforcing its role in combating infectious diseases worldwide.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Streptomycin

Retail & reference prices across 9 markets vs. India FOB export price of $6.24/unit

Global Price Benchmark for Streptomycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Streptomycin is listed in the FDA's Orange Book, indicating approved formulations.
United Kingdom	N/A	GBP	The NHS Drug Tariff provides pricing for medications; however, specific data for streptomycin is not specified.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees medication pricing, but specific streptomycin data is not specified.
Australia	N/A

Supply Chain Risk Assessment — Streptomycin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) synthesis. Approximately 60–70% of KSMs are imported from China, making the supply chain vulnerable to disruptions. This dependency is particularly critical for antibiotics like streptomycin, where the unavailability of KSMs can halt production.

Recent events have highlighted this vulnerability. In February 2026, Iran's blockade of the Strait of Hormuz disrupted global trade routes, including those vital for pharmaceutical shipments. This blockade led to significant delays and increased costs in transporting raw materials and finished products. (lemonde.fr) Such geopolitical tensions underscore the risks associated with concentrated sourcing of essential materials.

2Supplier Concentration & Single-Source Risk

Our proprietary data indicates that the top five Indian exporters of streptomycin account for 62.8% of total exports, with LABORATE PHARMACEUTICALS INDIA LTD leading at a 22.2% share. This concentration poses a risk, as disruptions affecting these key suppliers could significantly impact global streptomycin availability.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic API and KSM production. Notably, in October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and 6-APA, essential for antibiotics. While these initiatives are steps toward reducing import dependence, their impact on the streptomycin supply chain remains to be seen.

Access Complete Streptomycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 150 transactions across 36 markets.

Request Demo View Pricing

Frequently Asked Questions — Streptomycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top streptomycin exporters from India?

The leading streptomycin exporters from India are LABORATE PHARMACEUTICALS INDIA LTD, ASHISH LIFE SCIENCE PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, and 5 others. LABORATE PHARMACEUTICALS INDIA LTD leads with 22.2% market share ($127.3K). The top 5 suppliers together control 62.8% of total export value.

What is the total export value of streptomycin from India?

The total export value of streptomycin from India is $573.8K, recorded across 150 shipments from 57 active exporters to 36 countries. The average shipment value is $3.8K.

Which countries import streptomycin from India?

India exports streptomycin to 36 countries. The top importing countries are SAUDI ARABIA (28.9%), NIGERIA (22.2%), UNITED ARAB EMIRATES (17.1%), TAJIKISTAN (11.8%), ALGERIA (8.2%), which together account for 88.2% of total export value.

What is the HS code for streptomycin exports from India?

The primary HS code for streptomycin exports from India is 30041070. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Streptomycin

Streptomycin

Top Streptomycin Exporters from India

Top Countries Importing Streptomycin from India

Who Supplies Streptomycin to India?

Quick Facts

Related Tuberculosis Medications

Related Analysis

Need Details?

Regulatory Landscape — Streptomycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Streptomycin

Supply Chain Risk Assessment — Streptomycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Streptomycin Trade Intelligence

Frequently Asked Questions — Streptomycin Exports from India

Who are the top streptomycin exporters from India?

What is the total export value of streptomycin from India?

Which countries import streptomycin from India?

What is the HS code for streptomycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of streptomycin exports from India?

Which ports handle streptomycin exports from India?

Why is India a leading exporter of streptomycin?

What certifications do Indian streptomycin exporters need?

How many buyers import streptomycin from India?

What is the market share of the top streptomycin exporter from India?

Analysis Methodology